CD274 and non-small cell lung carcinoma: To our knowledge, this study is the first to examine the clinical characteristics of ORD and assess the clinical value of LCT in metastatic NSCLC patients treated with PD-1/PD-L1 inhibitors, offering preliminary evidence for the potential clinical significance of consolidative radiotherapy in this patient group.